These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 22888521)

  • 1. Comparison of prediction models for blood brain barrier permeability and analysis of the molecular descriptors.
    Wu ZY; Pan J; Yuan Y; Hui AL; Yang Y; Zhou A
    Pharmazie; 2012 Jul; 67(7):628-34. PubMed ID: 22888521
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In silico prediction of blood brain barrier permeability: an Artificial Neural Network model.
    Garg P; Verma J
    J Chem Inf Model; 2006; 46(1):289-97. PubMed ID: 16426064
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ADME evaluation in drug discovery. 1. Applications of genetic algorithms to the prediction of blood-brain partitioning of a large set of drugs.
    Hou T; Xu X
    J Mol Model; 2002 Dec; 8(12):337-49. PubMed ID: 12541001
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modelling blood-brain barrier partitioning using Bayesian neural nets.
    Winkler DA; Burden FR
    J Mol Graph Model; 2004 Jul; 22(6):499-505. PubMed ID: 15182809
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prediction of blood-brain partitioning: a model based on molecular electronegativity distance vector descriptors.
    Zhang YH; Xia ZN; Qin LT; Liu SS
    J Mol Graph Model; 2010 Sep; 29(2):214-20. PubMed ID: 20637670
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A prediction model for blood-brain barrier permeation and analysis on its parameter biologically.
    Chen Y; Zhu QJ; Pan J; Yang Y; Wu XP
    Comput Methods Programs Biomed; 2009 Sep; 95(3):280-7. PubMed ID: 19473718
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysing molecular polar surface descriptors to predict blood-brain barrier permeation.
    Shityakov S; Neuhaus W; Dandekar T; Förster C
    Int J Comput Biol Drug Des; 2013; 6(1-2):146-56. PubMed ID: 23428480
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predicting penetration across the blood-brain barrier from simple descriptors and fragmentation schemes.
    Zhao YH; Abraham MH; Ibrahim A; Fish PV; Cole S; Lewis ML; de Groot MJ; Reynolds DP
    J Chem Inf Model; 2007; 47(1):170-5. PubMed ID: 17238262
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In-silico prediction of blood-brain barrier permeability.
    Yan A; Liang H; Chong Y; Nie X; Yu C
    SAR QSAR Environ Res; 2013 Jan; 24(1):61-74. PubMed ID: 23092117
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predicting human plasma protein binding of drugs using plasma protein interaction QSAR analysis (PPI-QSAR).
    Li H; Chen Z; Xu X; Sui X; Guo T; Liu W; Zhang J
    Biopharm Drug Dispos; 2011 Sep; 32(6):333-42. PubMed ID: 21800312
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Blood-brain barrier permeability mechanisms in view of quantitative structure-activity relationships (QSAR).
    Bujak R; Struck-Lewicka W; Kaliszan M; Kaliszan R; Markuszewski MJ
    J Pharm Biomed Anal; 2015 Apr; 108():29-37. PubMed ID: 25703237
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ionization-specific QSAR models of blood-brain penetration of drugs.
    Lanevskij K; Japertas P; Didziapetris R; Petrauskas A
    Chem Biodivers; 2009 Nov; 6(11):2050-4. PubMed ID: 19937840
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Investigating the utility of momentum-space descriptors for predicting blood-brain barrier penetration.
    Al-Fahemi JH; Cooper DL; Allan NL
    J Mol Graph Model; 2007 Oct; 26(3):607-12. PubMed ID: 17300970
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of various PAMPA models to identify the most discriminating method for the prediction of BBB permeability.
    Mensch J; Melis A; Mackie C; Verreck G; Brewster ME; Augustijns P
    Eur J Pharm Biopharm; 2010 Mar; 74(3):495-502. PubMed ID: 20067834
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro models for the blood-brain barrier.
    Garberg P; Ball M; Borg N; Cecchelli R; Fenart L; Hurst RD; Lindmark T; Mabondzo A; Nilsson JE; Raub TJ; Stanimirovic D; Terasaki T; Oberg JO; Osterberg T
    Toxicol In Vitro; 2005 Apr; 19(3):299-334. PubMed ID: 15713540
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In silico model of drug permeability across sublingual mucosa.
    Goswami T; Kokate A; Jasti BR; Li X
    Arch Oral Biol; 2013 May; 58(5):545-51. PubMed ID: 23123066
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predicting water solubility of congeners: chloronaphthalenes--a case study.
    Puzyn T; Mostrag A; Falandysz J; Kholod Y; Leszczynski J
    J Hazard Mater; 2009 Oct; 170(2-3):1014-22. PubMed ID: 19524360
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prediction of blood-brain barrier permeation of α-adrenergic and imidazoline receptor ligands using PAMPA technique and quantitative-structure permeability relationship analysis.
    Vucicevic J; Nikolic K; Dobričić V; Agbaba D
    Eur J Pharm Sci; 2015 Feb; 68():94-105. PubMed ID: 25542610
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An in vitro transport model for rapid screening and predicting the permeability of candidate compounds at blood-brain barrier.
    Yang ZH; Sun X; Mei C; Sun XB; Liu XD; Chang Q
    J Asian Nat Prod Res; 2011 Dec; 13(12):1087-97. PubMed ID: 22115032
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Qualitative and quantitative structure-activity relationship modelling for predicting blood-brain barrier permeability of structurally diverse chemicals.
    Gupta S; Basant N; Singh KP
    SAR QSAR Environ Res; 2015; 26(2):95-124. PubMed ID: 25629764
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.